Fig. 2. Effects of theracurmin on the accumulation of hepatic TG and CHO in HFD-fed mice. (A, B) Measurement of accumulation of TG and CHO in the liver from mice of each group. Data were expressed as mean ± SEM statistically analyzed by LSD-test methods. Significant versus normal control, ##p< 0.01; significant versus HFD-fed group, **p< 0.01 (n = 10). G1: ND (normal saline), n = 10; G2: HFD + vehicle (normal saline), n = 10; G3: HFD + theracurmin (500 mg/kg/day), n = 10; G4: HFD + theracurmin (1,000 mg/kg/day), n = 10; G5: HFD + theracurmin (2,000 mg/kg/day), n = 10; G6: HFD + reference control (silymarin 25 mg/kg/day), n = 10.
© ToxicolRes
